SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    R. Lorie Ros, Lauren M. Kucirka, Priyanka Govindan, Harini Sarathy, Robert A. Montgomery, Dorry L. Segev, Patient attitudes toward CDC high infectious risk donor kidney transplantation: inferences from focus groups, Clinical Transplantation, 2012, 26, 2
  2. 2
    Theresa R. Harring, Christine A. O’Mahony, John A. Goss, Extended Donors in Liver Transplantation, Clinics in Liver Disease, 2011, 15, 4, 879

    CrossRef

  3. 3
    Lauren M Kucirka, Andrew L Singer, Dorry L Segev, High infectious risk donors: what are the risks and when are they too high?, Current Opinion in Organ Transplantation, 2011, 16, 2, 256

    CrossRef

  4. 4
    Peter P. Reese, Scott D. Halpern, David A. Asch, Roy Bloom, Howard Nathan, Richard Hasz, Joseph Roth, William Reitsma, Louis Krefski, Fred Goerlitz, Gina DeLauro, Emily Blumberg, Francis L. Weng, Arthur Caplan, Arwin Thomasson, Justine Shults, Harold I. Feldman, Longer-Term Outcomes After Kidney Transplantation From Seronegative Deceased Donors at Increased Risk for Blood-Borne Viral Infection, Transplantation, 2011, 91, 11, 1211

    CrossRef

  5. 5
    L. M. Kucirka, H. Sarathy, P. Govindan, J. H. Wolf, T. A. Ellison, L. J. Hart, R. A. Montgomery, R. L. Ros, D. L. Segev, Risk of Window Period Hepatitis-C Infection in High Infectious Risk Donors: Systematic Review and Meta-Analysis, American Journal of Transplantation, 2011, 11, 6
  6. 6
    L. M. Kucirka, H. Sarathy, P. Govindan, J. H. Wolf, T. A. Ellison, L. J. Hart, R. A. Montgomery, R. L. Ros, D. L. Segev, Risk of Window Period HIV Infection in High Infectious Risk Donors: Systematic Review and Meta-Analysis, American Journal of Transplantation, 2011, 11, 6
  7. 7
    Robert C. Huang, Jay A. Fishman, Screening of Deceased Organ Donors: No Easy Answers, Transplantation, 2011, 91, 2, 146

    CrossRef

  8. 8
    E. J. Gordon, N. Beauvais, N. Theodoropoulos, J. Hanneman, G. McNatt, D. Penrod, S. Jensen, J. Franklin, L. Sherman, M. G. Ison, The Challenge of Informed Consent for Increased Risk Living Donation and Transplantation, American Journal of Transplantation, 2011, 11, 12
  9. 9
    M. G. Ison, E. Llata, C. S. Conover, J. J. Friedewald, S. I. Gerber, A. Grigoryan, W. Heneine, J. M. Millis, D. M. Simon, C.-G. Teo, M. J. Kuehnert, Transmission of Human Immunodeficiency Virus and Hepatitis C Virus From an Organ Donor to Four Transplant Recipients, American Journal of Transplantation, 2011, 11, 6
  10. 10
    John F. Renz, A critical analysis of liver allograft utilization from the US deceased donor pool, Liver Transplantation, 2010, 16, 5
  11. 11
    K. I. Duan, M. J. Englesbe, M. L. Volk, Centers for Disease Control ‘High-Risk’ Donors and Kidney Utilization, American Journal of Transplantation, 2010, 10, 2
  12. 12
    D. Michael Strong, Naoshi Shinozaki, Coding and traceability for cells, tissues and organs for transplantation, Cell and Tissue Banking, 2010, 11, 4, 305

    CrossRef

  13. 13
    Lauren M. Kucirka, Nabil N. Dagher, Robert A. Montgomery, Dorry L. Segev, Andrew L. Singer, High infectious risk organ donors in kidney transplantation: Risks, benefits, and current practices, Dialysis & Transplantation, 2010, 39, 5
  14. 14
    Eric Y Wong, Indira K Hewlett, HIV diagnostics: challenges and opportunities, HIV Therapy, 2010, 4, 4, 399

    CrossRef

  15. 15
    Michele I. Morris, Staci A. Fischer, Michael G. Ison, Infections Transmitted by Transplantation, Infectious Disease Clinics of North America, 2010, 24, 2, 497

    CrossRef

  16. 16
    A. Humar, M. Morris, E. Blumberg, R. Freeman, J. Preiksaitis, B. Kiberd, E. Schweitzer, S. Ganz, A. Caliendo, J. P. Orlowski, B. Wilson, C. Kotton, M. Michaels, S. Kleinman, S. Geier, B. Murphy, M. Green, M. Levi, G. Knoll, D. Segev, S. Brubaker, R. Hasz, D. J. Lebovitz, D. Mulligan, K. O’Connor, T. Pruett, M. Mozes, I. Lee, F. Delmonico, S. Fischer, Nucleic Acid Testing (NAT) of Organ Donors: Is the ‘Best’ Test the Right Test? A Consensus Conference Report, American Journal of Transplantation, 2010, 10, 4
  17. 17
    R.M. Taylor, R.E. Pietroski, M. Hagan, A.B. Eisenbrey, R.J. Fontana, Seropositive Abdominal and Thoracic Donor Organs Are Largely Underutilized, Transplantation Proceedings, 2010, 42, 10, 4479

    CrossRef

  18. 18
    ROBIN DEWAR, DEBORAH GOLDSTEIN, FRANK MALDARELLI, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 2010,

    CrossRef

  19. 19
    Camille Nelson Kotton, Donor-Derived Infections in Transplant Patients, Clinical Microbiology Newsletter, 2009, 31, 9, 63

    CrossRef

  20. 20
    P. A. Grossi, J. A. Fishman, Donor-Derived Infections in Solid Organ Transplant Recipients, American Journal of Transplantation, 2009, 9,
  21. 21
    Joseph Ahn, Stanley Cohen, Reply: Transmission of human immunodeficiency virus and hepatitis C virus through liver transplantation, Liver Transplantation, 2009, 15, 5
  22. 22
    S. A. Fischer, R. K. Avery, Screening of Donor and Recipient Prior to Solid Organ Transplantation, American Journal of Transplantation, 2009, 9,
  23. 23
    E. A. Blumberg, P. Stock, Solid Organ Transplantation in the HIV-Infected Patient, American Journal of Transplantation, 2009, 9,
  24. 24
    Michael G. Ison, The Epidemiology and Prevention of Donor-Derived Infections, Advances in Chronic Kidney Disease, 2009, 16, 4, 234

    CrossRef

  25. 25
    Michael G. Ison, John J. Friedewald, Transmission of human immunodeficiency virus and hepatitis C virus through liver transplantation, Liver Transplantation, 2009, 15, 5
  26. 26
    Michael G. Ison, Valentina Stosor, Transplantation of high-risk donor organs: a survey of US solid organ transplant center practices as reported by transplant infectious diseases physicians, Clinical Transplantation, 2009, 23, 6
  27. 27
    Shimon Kusne, Regarding unexpected severe and life-threatening donor-transmitted viral infections and use of high-risk behavior donors, Liver Transplantation, 2008, 14, 11